Seek Returns

BIIB vs. ELAN: Biogen vs. Elanco Animal Health Stock Comparison

How do Biogen (BIIB) and Elanco Animal Health (ELAN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Biogen (BIIB) and Elanco Animal Health (ELAN) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but BIIB is classified in Biotechnology while ELAN is classified in Pharmaceuticals.

Company profile comparison for Biogen (BIIB) and Elanco Animal Health (ELAN)
Profile ItemBIIBELAN
NameBiogen Inc.Elanco Animal Health Incorporated
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnologyPharmaceuticals
GICS Sub-IndustryBiotechnologyPharmaceuticals
Market Capitalization36.71 billion USD12.86 billion USD
CurrencyUSDUSD
ExchangeNasdaqNYSE
Listing DateSeptember 17, 1991September 20, 2018
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

BIIB
ELAN
GSPC
Loading price history…
Biogen (BIIB) vs. Elanco Animal Health (ELAN), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Biogen (BIIB) and Elanco Animal Health (ELAN). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Biogen (BIIB) and Elanco Animal Health (ELAN). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Biogen (BIIB) and Elanco Animal Health (ELAN)
MetricBIIBELAN
Total Return (1Y)65.44%24.03%
Total Return (3Y, Annualized)4.62%37.47%
Total Return (5Y, Annualized)-0.96%-4.24%

Risk Profile

Drawdown History

BIIB
ELAN
GSPC
Loading price history…
Biogen (BIIB) vs. Elanco Animal Health (ELAN), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Biogen (BIIB) and Elanco Animal Health (ELAN). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Elanco Animal Health (ELAN) has an aggressive beta of 1.65, indicating higher sensitivity to broad-market moves, while Biogen (BIIB) is defensive at 0.08 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk profile metrics for Biogen (BIIB) and Elanco Animal Health (ELAN)
MetricBIIBELAN
Volatility (1Y, Annualized)34.58%43.57%
Beta (5Y)0.081.65
Max Drawdown (5Y)-64.35%-75.59%
Avg. Volume (3M)1.05M5.65M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
BIIB and ELAN are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Biogen (BIIB) and Elanco Animal Health (ELAN)
MetricBIIBELAN
Sharpe Ratio (1Y)1.770.45
Sortino Ratio (1Y)2.770.66

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Biogen (BIIB) earns 1.87% on shareholders’ equity, ranked against its industry; Elanco Animal Health (ELAN) has no ROE this period.

BIIB

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.87%

Max
109.18%
Q3
6.23%
BIIB
1.87%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ELAN
--
Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): ELAN does not report ROE, so it has no value marker; BIIB is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Net Margin (TTM)

Elanco Animal Health (ELAN) reports a negative net margin of -2.86%, usually indicating a net loss over the period. Meanwhile Biogen (BIIB) reports 3.38%, ranking against industry peers normally.

BIIB

Pharmaceuticals, Biotechnology & Life Sciences industry group

3.38%

Max
18.05%
Q3
4.78%
BIIB
3.38%
Median
0.00%
Q1
-4.14%
Min
-17.05%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

-2.86%

Max
18.05%
Q3
4.78%
Median
0.00%
ELAN
-2.86%
Q1
-4.14%
Min
-17.05%
Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Biogen (BIIB) at 24.12% operates in the top operating margin quartile, ahead of Elanco Animal Health (ELAN) at 6.64%, which runs around its industry’s norm.

BIIB

Pharmaceuticals, Biotechnology & Life Sciences industry group

24.12%

Max
83.12%
BIIB
24.12%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.64%

Max
83.12%
Q3
14.77%
ELAN
6.64%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Biogen (BIIB) and Elanco Animal Health (ELAN)
MetricBIIBELAN
ROE (TTM)1.87%--
ROA (TTM)4.94%--
Net Margin (TTM)3.38%-2.86%
Operating Margin (TTM)24.12%6.64%
Gross Margin (TTM)75.77%56.18%

Growth

Revenue Growth

Both Biogen (BIIB) at 2.22% and Elanco Animal Health (ELAN) at 6.22% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): A comparison of their Revenue Growth across different time periods.

EPS Growth

Biogen (BIIB) at -21.38% is around its peer norm for EPS growth, while Elanco Animal Health (ELAN) at -169.12% drops into the bottom quartile, signaling weaker earnings momentum.

Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Biogen (BIIB) and Elanco Animal Health (ELAN)
MetricBIIBELAN
Revenue Growth (YoY)2.22%6.22%
Revenue Growth (3Y CAGR)-0.94%2.25%
EPS Growth (YoY)-21.38%-169.12%
EPS Growth (3Y CAGR)-25.04%--

Financial Strength

Current Ratio (MRQ)

Short-term liquidity can only be read on one side of this pairing: Biogen (BIIB) shows current ratio of 1.95 against its industry benchmark, while Elanco Animal Health (ELAN) has no reading this period.

BIIB

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.95

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
BIIB
1.95
Min
0.10

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
Min
0.10
ELAN
--
Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): ELAN does not report current ratio, so it has no value marker; BIIB is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Debt / Equity (MRQ)

Both Biogen (BIIB) at 0.41 and Elanco Animal Health (ELAN) at 0.64 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

BIIB

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.41

Max
1.42
Q3
0.65
BIIB
0.41
Median
0.15
Q1
0.02
Min
0.00

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.64

Max
1.42
Q3
0.65
ELAN
0.64
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Biogen (BIIB) and Elanco Animal Health (ELAN)
MetricBIIBELAN
Current Ratio (MRQ)1.95--
Debt / Equity (MRQ)0.410.64
Net Debt / EBITDA1.973.49

Dividends

Dividend Yield (TTM)

Neither Biogen (BIIB) nor Elanco Animal Health (ELAN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

BIIB

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

BIIB
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Neither Biogen (BIIB) nor Elanco Animal Health (ELAN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

BIIB

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

BIIB
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ELAN
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Biogen (BIIB) and Elanco Animal Health (ELAN)
MetricBIIBELAN
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: Biogen (BIIB) trades at 107.51 times trailing earnings, ranked against its peers, while Elanco Animal Health (ELAN) has no P/E ratio this period.

BIIB

Pharmaceuticals, Biotechnology & Life Sciences industry group

107.51

BIIB
107.51
Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
ELAN
--
Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): ELAN does not report P/E ratio, so it has no value marker; BIIB is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

Elanco Animal Health (ELAN) at 2.50 sits in the cheaper P/S ratio quartile while Biogen (BIIB) at 3.57 prices around its industry’s middle — ELAN costs less per dollar of sales, though read it alongside growth and margins.

BIIB

Pharmaceuticals, Biotechnology & Life Sciences industry group

3.57

Max
58.18
Q3
25.77
Median
7.30
BIIB
3.57
Q1
3.01
Min
0.01

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.50

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
ELAN
2.50
Min
0.01
Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

On P/B ratio, both Biogen (BIIB) at 1.94 and Elanco Animal Health (ELAN) at 1.95 are valued close to their industries’ norm against book — neither stands out from peers.

BIIB

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.94

Max
13.53
Q3
6.54
Median
3.25
BIIB
1.94
Q1
1.69
Min
-5.59

ELAN

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.95

Max
13.53
Q3
6.54
Median
3.25
ELAN
1.95
Q1
1.69
Min
-5.59
Loading chart…
Biogen (BIIB) vs. Elanco Animal Health (ELAN): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Biogen (BIIB) and Elanco Animal Health (ELAN)
MetricBIIBELAN
P/E Ratio (TTM)107.51--
P/S Ratio (TTM)3.572.50
P/B Ratio (MRQ)1.941.95
Free Cash Flow Yield (TTM)2.20%--